Ya-Jen Chang

Prof. Ya-Jen Chang

Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
CTChristina Li-Ping Thio
Christina Li-Ping Thio
PCPo-Yu Chi
Po-Yu Chi
ALAlan Chuan-Ying Lai
Alan Chuan-Ying Lai
YCYa-Jen Chang
Ya-Jen Chang

11 September 2023 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
PDF file
CTChristina Li-Ping Thio
Christina Li-Ping Thio
YCYa-Jen Chang
Ya-Jen Chang
A dysregulated type 2 immune response is one of the fundamental causes of allergic asthma. Although Th2 cells are undoubtedly central to the pathogenesis of allergic asthma, the discovery of group 2 innate lymphoid cells (ILC2s) has added another layer of complexity to the etiology of this chronic disease. Through their inherent innate type 2 responses, ILC2s not only contribute to the initiation of airway inflammation but also orchestrate the recruitment and activation of other members of innate and adaptive immunity, further amplifying the inflammatory response. Moreover, ILC2s exhibit substantial cytokine plasticity, as evidenced by their ability to produce type 1- or type 17-associated cytokines under appropriate conditions, underscoring their potential contribution to nonallergic, neutrophilic asthma. Thus, understanding the mechanisms of ILC2 functions is pertinent. In this review, we present an overview of the current knowledge on ILC2s in asthma and the regulatory factors that modulate lung ILC2 functions in various experimental mouse models of asthma and in humans.

7 June 2023 in Science Translational Medicine
Verified
Journal Article
Closed access
CTChing-Hui Tsai
Ching-Hui Tsai
ALAlan Chuan-Ying Lai
Alan Chuan-Ying Lai
YLYu-Cheng Lin
Yu-Cheng Lin
PCPo-Yu Chi
Po-Yu Chi
YCYun-Chi Chen
Yun-Chi Chen
LLLee-Yung Ling
Lee-Yung Ling
The association between neutrophil extracellular traps (NETs) and response to inhaled corticosteroids (ICS) in asthma is unclear. To better understand this relationship, we analyzed the blood transcriptomes from children with controlled and uncontrolled asthma in the Taiwanese Consortium of Childhood Asthma Study using weighted gene coexpression network analysis and pathway enrichment methods. We identified 298 uncontrolled asthma-specific differentially expressed genes and one gene module associated with neutrophil-mediated immunity, highlighting a potential role for neutrophils in uncontrolled asthma. We also found that NET abundance was associated with nonresponse to ICS in patients. In a neutrophilic airway inflammation murine model, steroid treatment could not suppress neutrophilic inflammation and airway hyperreactivity. However, NET disruption with deoxyribonuclease I (DNase I) efficiently inhibited airway hyperreactivity and inflammation. Using neutrophil-specific transcriptomic profiles, we found that CCL4L2 was associated with ICS nonresponse in asthma, which was validated in human and murine lung tissue. CCL4L2 expression was also negatively correlated with pulmonary function change after ICS treatment. In summary, steroids fail to suppress neutrophilic airway inflammation, highlighting the potential need to use alternative therapies such as leukotriene receptor antagonists or DNase I that target the neutrophil-associated phenotype. Furthermore, these results highlight CCL4L2 as a potential therapeutic target for individuals with asthma refractory to ICS.

1 January 2021 in Theranostics
Verified
Journal Article
Open access
WCWei-Yu Chen
Wei-Yu Chen
YWYi-Hsiu Wu
Yi-Hsiu Wu
TTTzu-Hsien Tsai
Tzu-Hsien Tsai
RLRu-Fang Li
Ru-Fang Li
ALAlan Chuan-Ying Lai
Alan Chuan-Ying Lai
YCYa-Jen Chang
Ya-Jen Chang
Rationale: The major cause of heart failure is myocardium death consequent to detrimental cardiac remodeling and fibrosis following myocardial infarction. The cardiac protective cytokine interleukin (IL)-33, which signals by ST2 receptor binding, is associated with group 2 innate lymphoid cell (ILC2) activation and regulates tissue homeostasis and repair following tissue injury in various tissues. However, the distribution and role of IL-33-responsive ILC2s in cardiac fibrosis remain unclear. In this study, we elucidated the roles of IL-33-responsive cardiac-resident ILC2s and IL-33-mediated immunomodulatory functions in cardiac fibrosis.

17 October 2019 in Allergy
Verified
Journal Article
Closed access
PDF file
YWYi-Hsiu Wu
Yi-Hsiu Wu
ALAlan Chuan‐Ying Lai
Alan Chuan‐Ying Lai
PCPo‐Yu Chi
Po‐Yu Chi
CTChristina Li‐Ping Thio
Christina Li‐Ping Thio
WCWei‐Yu Chen
Wei‐Yu Chen
YCYa-Jen Chang
Ya-Jen Chang

1 July 2016 in Biomaterials
Verified
Journal Article
Closed access
SWSheng Hung Wang
Sheng Hung Wang
ALAndy Chi-Lung Lee
Andy Chi-Lung Lee
ICI-Ju Chen
I-Ju Chen
NCNai-Chuan Chang
Nai-Chuan Chang
HWHan-Chung Wu
Han-Chung Wu
JYJohn Yu
John Yu